Navigation Links
EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
Date:5/15/2009

lso has an approved IND application for Panzem(R) in rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

    CONTACT:
    Ginny Dunn
    Associate Director, Corporate Communications & Investor Relations
    EntreMed, Inc.
    240.864.2643


'/>"/>
SOURCE EntreMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
2. EntreMed to Present at the New York Society of Security Analysts Industry Conference
3. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
4. EntreMed Reports Third Quarter 2008 Financial Results
5. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
6. EntreMed to Present at BioPartnering Europe Conference
7. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
8. EntreMed Reports Second Quarter 2008 Financial Results
9. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
10. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 RegeneCure announced today ... AMCA Guided Bone Regeneration (GBR) Dental Membrane as a bone ... common problem encountered when patients have a tooth replaced with ... to house the implant. Consequently there is often a need ... natural bone regenerates. The bone substitute material, in turn, needs ...
(Date:6/18/2013)... June 18, 2013 The "Bioinformatics Market By ... Knowledge Management Tools & Data Analysis Services) & Application (Genomics, ... the Major Market Drivers, Restraints, and Opportunities in ... Asia-Pacific and Rest of World. ... 22 Figures 364 ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics [Diabetes & Oncology] ... to their offering.      (Logo: ...
(Date:6/18/2013)... Mississauga, Ontario (PRWEB) June 18, 2013 ... specializing in Proof of Concept and Phase I-IV ... a strategic alliance with Northern Air Environmental Technologies ... company, for the deployment, monitoring, and servicing of ... Asthma, and Ocular clinical trials. ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 2Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 3
... Mass., June 3 Associates of Cape Cod,Inc. ... detection,products, today announced that the Fungitell(R) assay kit, ... component, has,been CE marked, which enables distribution in ... has been included in both the Infectious,Disease Society ...
... iCAD, Inc. (Nasdaq:,ICAD), an industry-leading provider of Computer-Aided ... Executive Officer, and,Darlene Deptula-Hicks, Executive Vice President and ... corporate update at the Seventh Annual,Needham and Company ... 2008 at 2:00 p.m., (Eastern Daylight Time) at ...
... Calif., June 3 NeurogesX, Inc.,(Nasdaq: NGSX ... novel pain management therapies, announced that it,submitted an ... Food,and Drug Administration for the clinical development of ... of capsaicin. The Company further announced that the ...
Cached Biology Technology:Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease 2Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease 3iCAD to Present at Seventh Annual Needham and Company Biotechnology and Medical Technology Conference 2NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998 2NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998 3
(Date:6/18/2013)... Ph.D., Medical Research Council, Laboratory of Molecular Biology, ... 2013 ICAAC Young Investigator Award. Torrent is being ... the first algorithm to predict antimicrobial regions in ... "we are now applying this algorithm to interrogate ... peptide leads with very appealing results." , ...
(Date:6/18/2013)... The herbal extract of a yellow-flowered mountain plant ... the lifespan of fruit fly populations by an average ... But it,s how Rhodiola rosea , ... the attention of study leaders Mahtab Jafari and Sam ... a manner completely unrelated to dietary restriction and affects ...
(Date:6/18/2013)... University of Adelaide shows that weight gain and increased ... linked to a higher IQ at early school age. , The ... analysed data from more than 13,800 children who were born full-term. ... , show that babies who put on 40% of their birthweight ... by the time they were six years of age, compared with ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Marc Torrent 2Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2
... never reach the tumors they,re intended to treat, ... the blood vessels feeding the tumors are abnormal"leaky ... Judah Folkman, MD, founder of the Vascular Biology ... researchers have discovered an explanation for these abnormalities ...
... About 75% of fertilizers and fertilizer technology used around ... 1950s to 1970s by scientists and engineers at the ... John Shields, a former TVA official. Shields is now ... Fertility and Agricultural Development, based in Muscle Shoals, Alabama. ...
... of potentially beneficial bioactive microorganisms within plants they collected ... distinct that they may be the first members of ... - fungal and bacterial microorganisms living within the inner ... Forest Expedition and Laboratory course at Yale will be ...
Cached Biology News:Normalizing tumor vessels to improve cancer therapy 2Normalizing tumor vessels to improve cancer therapy 3TVA fertilizer technology used worldwide -- but few new products since 1970s 2TVA fertilizer technology used worldwide -- but few new products since 1970s 3TVA fertilizer technology used worldwide -- but few new products since 1970s 4Yale undergrads' Amazon trip yields a treasure trove of diversity 2
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
... is generated from rabbits immunized with a ... 50~150 of human PLAU. Purified rabbit polyclonal ... sodium azide. This antibody is purified through ... with both high and low pH buffers ...
... Lyophilized. Lyophilized from 2 mM sodium phosphate ... liver. Cathepsin D is a major lysosomal ... a 52 kDa proenzyme. Overexpression of cathepsin ... with higher risk of relapse and metastasis. ...
Acetate Plate Sealers 100/Box...
Biology Products: